Figure 4.

Additional individual ambulatory care expenditures attributable to T2 DM by treatment phase and resource category in 2010*.*% calculated by treatment line; ex: additional costs in monotherapy = 53% pharmacy + 9% consultations + 5% nursing care + 32% others.

Guelfucci et al. BMC Endocrine Disorders 2013 13:15   doi:10.1186/1472-6823-13-15
Download authors' original image